Kancera AB (Sweden) Buy Hold or Sell Recommendation
KAN Stock | SEK 1.50 0.01 0.67% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Kancera AB is 'Strong Sell'. Macroaxis provides Kancera AB buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KAN positions. The advice algorithm takes into account all of Kancera AB's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Kancera AB's buy or sell advice are summarized below:
Real Value 1.44 | Hype Value 1.5 | Market Value 1.5 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kancera AB given historical horizon and risk tolerance towards Kancera AB. When Macroaxis issues a 'buy' or 'sell' recommendation for Kancera AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Kancera |
Execute Kancera AB Buy or Sell Advice
The Kancera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kancera AB. Macroaxis does not own or have any residual interests in Kancera AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kancera AB's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Kancera AB Trading Alerts and Improvement Suggestions
Kancera AB generated a negative expected return over the last 90 days | |
Kancera AB has high historical volatility and very poor performance | |
Kancera AB may become a speculative penny stock | |
The company reported the revenue of 1.7 M. Net Loss for the year was (45.69 M) with profit before overhead, payroll, taxes, and interest of 1.7 M. | |
Kancera AB has accumulated about 106.52 M in cash with (44.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08. | |
Roughly 14.0% of the company outstanding shares are owned by corporate insiders |
Kancera AB Returns Distribution Density
The distribution of Kancera AB's historical returns is an attempt to chart the uncertainty of Kancera AB's future price movements. The chart of the probability distribution of Kancera AB daily returns describes the distribution of returns around its average expected value. We use Kancera AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kancera AB returns is essential to provide solid investment advice for Kancera AB.
Mean Return | -1.02 | Value At Risk | -14.07 | Potential Upside | 8.66 | Standard Deviation | 8.03 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kancera AB historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kancera AB Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kancera AB or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kancera AB's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kancera stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -1.23 | |
β | Beta against NYSE Composite | 2.45 | |
σ | Overall volatility | 8.10 | |
Ir | Information ratio | -0.14 |
Kancera AB Volatility Alert
Kancera AB is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kancera AB's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kancera AB's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Kancera AB Fundamentals Vs Peers
Comparing Kancera AB's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Kancera AB's direct or indirect competition across all of the common fundamentals between Kancera AB and the related equities. This way, we can detect undervalued stocks with similar characteristics as Kancera AB or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Kancera AB's fundamental indicators could also be used in its relative valuation, which is a method of valuing Kancera AB by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Kancera AB to competition |
Fundamentals | Kancera AB | Peer Average |
Return On Equity | -0.47 | -0.31 |
Return On Asset | -0.27 | -0.14 |
Operating Margin | (72.39) % | (5.51) % |
Current Valuation | 14.76 M | 16.62 B |
Shares Outstanding | 79.53 M | 571.82 M |
Shares Owned By Insiders | 13.72 % | 10.09 % |
Shares Owned By Institutions | 2.86 % | 39.21 % |
Price To Earning | (11.64) X | 28.72 X |
Price To Book | 1.44 X | 9.51 X |
Price To Sales | 168.19 X | 11.42 X |
Revenue | 1.7 M | 9.43 B |
Gross Profit | 1.7 M | 27.38 B |
EBITDA | (45.35 M) | 3.9 B |
Net Income | (45.69 M) | 570.98 M |
Cash And Equivalents | 106.52 M | 2.7 B |
Cash Per Share | 0.08 X | 5.01 X |
Total Debt | 442 K | 5.32 B |
Debt To Equity | 33.30 % | 48.70 % |
Current Ratio | 2.11 X | 2.16 X |
Book Value Per Share | 1.50 X | 1.93 K |
Cash Flow From Operations | (44.12 M) | 971.22 M |
Earnings Per Share | (0.87) X | 3.12 X |
Target Price | 1.6 | |
Number Of Employees | 5 | 18.84 K |
Beta | 1.28 | -0.15 |
Market Capitalization | 262.69 M | 19.03 B |
Total Asset | 133.64 M | 29.47 B |
Working Capital | 11 M | 1.48 B |
Current Asset | 16 M | 9.34 B |
Current Liabilities | 5 M | 7.9 B |
Net Asset | 133.64 M |
Kancera AB Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kancera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 12520.47 | |||
Daily Balance Of Power | 0.1429 | |||
Rate Of Daily Change | 1.01 | |||
Day Median Price | 1.52 | |||
Day Typical Price | 1.51 | |||
Price Action Indicator | (0.01) | |||
Period Momentum Indicator | 0.01 |
About Kancera AB Buy or Sell Advice
When is the right time to buy or sell Kancera AB? Buying financial instruments such as Kancera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kancera AB in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
View All Next | Launch |
Check out Kancera AB Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Kancera Stock analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |